share_log
Moomoo 24/7 ·  Apr 16 07:00
Voyager Therapeutics Announces Selection of Development Candidate for Gba1 Program in Collaboration With Neurocrine Biosciences, Triggering Milestone Payment
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment